Reed, Murray Bruce http://orcid.org/0000-0002-4873-608X
Handschuh, Patricia Anna http://orcid.org/0000-0003-3524-3646
Schmidt, Clemens http://orcid.org/0000-0003-3138-6869
Murgaš, Matej http://orcid.org/0000-0001-7643-2182
Gomola, David http://orcid.org/0009-0002-2059-6481
Milz, Christian http://orcid.org/0000-0002-1347-0744
Klug, Sebastian http://orcid.org/0000-0001-8714-6608
Eggerstorfer, Benjamin http://orcid.org/0000-0002-3400-2181
Aichinger, Lisa http://orcid.org/0000-0002-5682-1639
Godbersen, Godber Mathis http://orcid.org/0000-0002-9739-0724
Nics, Lukas http://orcid.org/0000-0002-1034-876X
Traub-Weidinger, Tatjana http://orcid.org/0000-0003-1118-926X
Hacker, Marcus http://orcid.org/0000-0002-4222-4083
Lanzenberger, Rupert http://orcid.org/0000-0003-4641-9539
Hahn, Andreas http://orcid.org/0000-0001-9727-7580
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 15 January 2024
Accepted: 14 April 2024
First Online: 27 April 2024
Declarations
:
: R. Lanzenberger received travel grants and/or conference speaker honoraria within the last three years from Bruker BioSpin MR, Heel, and support from Siemens Healthcare regarding clinical research using PET/MR. He is a shareholder of the start-up company BM Health GmbH since 2019. M. Hacker received consulting fees and/or honoraria from Bayer Healthcare BMS, Eli Lilly, EZAG, GE Healthcare, Ipsen, ITM, Janssen, Roche, and Siemens Healthineers. No other potential conflicts of interest relevant to this article exist.
: Participants were reimbursed and insured during the study. The study was approved by the ethics committee of the Medical University of Vienna (ethics numbers: 2259/2017 and 2321/2019) and all procedures were carried out according to the Declaration of Helsinki.
: At the screening visit, all participants provided written informed consent after detailed explanation of the study protocol.